University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > Intelence

Intelence (etravirine)

Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor
Nonnucleoside reverse transcriptase inhibitors prevent HIV from using an enzyme called reverse transcriptase to make copies of itself. These drugs are also known as NNRTIs, nonnucleosides or "nonnukes."
gray line
transparent gif

Approved adult dosing

200 mg (one 200 mg tablet), twice a day after meals

  • Morning

    Intelence 200mg

    200 mg

  • Evening

    Intelence 200mg

    200 mg

Note: Intelence must be used with other anti-HIV medicines. It is intended for patients who are taking anti-HIV medicines but whose medicines are not controlling their HIV infection or whose virus is becoming resistant to treatment.

200 mg (two 100 mg tablets), twice a day after meals

  • Morning

    Intelence 100mgIntelence 100mg

    100 mg

  • Evening

    Intelence 100mgIntelence 100mg

    100 mg

Note: Intelence must be used with other anti-HIV medicines. It is intended for patients who are taking anti-HIV medicines but whose medicines are not controlling their HIV infection or whose virus is becoming resistant to treatment.

Notes on taking this medication

  • Take after a meal (do not take without food)
  • May dissolve in water and drink immediately. Rinse glass and drink the remainder.
  • Intelence can interact with other drugs; consult your medical provider

Side effects

  • Rash (usually is mild to moderate. If severe rash develops, contact your medical provider)
  • Nausea
  • Intelence has not been studied during pregnancy; tell your medical provider if you become pregnant while taking this drug

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

transparent gif
Contents
transparent gifScroll over drug name to see other names for the drug.
transparent gif
transparent gif
transparent gif